Idiopathic pulmonary fibrosis is a progressive and life-threatening lung disease but there are ASX companies bringing hope to ...

Qureight and Remedy Cell have collaborated to validate the mechanism of action of RC-0315 in the Phase Ib clinical trial for ...

Most online pulmonary rehabilitation videos are understandable but lack key disease-specific information for conditions other than COPD.

Katie Price has shared a heart-breaking update on her mother, Amy, who is fighting idiopathic pulmonary fibrosis (IPF). The ...

Katie Price has shared a heart-breaking update on her mother, Amy, who is fighting idiopathic pulmonary fibrosis (IPF). The ...

On the 74th birth anniversary of Zakir Hussain, fans and celebrities, including Shankar Mahadevan, paid heartfelt tributes to ...

A recent study from the Women’s Guild Lung Institute at Cedars-Sinai suggests that zinc could help reverse lung damage in ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

Scientists target senescent "zombie cells" with new drugs called senolytics, which may slow aging and prevent diseases like ...

The following is a summary of "Supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United States," published in the February 2025 issue of the Respiratory ...

Remedy Cell, a clinical-stage biopharmaceutical company focused on the development of proprietary cell-derived therapies for fibrotic diseases, and Qureight Ltd, a Core Imaging Laboratory with ...

Insilico Medicine has raised $110 million in Series E funding for its artificial intelligence-powered drug discovery ...